ketamine has been researched along with Epilepsy Syndromes in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ioku, T | 1 |
Inoue, T | 1 |
Kuki, I | 1 |
Imai, K | 1 |
Yamamoto, A | 1 |
Cho, M | 1 |
Caputo, D | 1 |
Iorio, R | 1 |
Vigevano, F | 1 |
Fusco, L | 1 |
2 other studies available for ketamine and Epilepsy Syndromes
Article | Year |
---|---|
[A case of febrile infection-related epilepsy syndrome requiring prolonged intensive care management: a trial of intravenous ketamine and intrathecal dexamethasone therapy].
Topics: Adolescent; Critical Care; Dexamethasone; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndromes | 2022 |
Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Topics: Adolescent; Anticonvulsants; Autoantibodies; Drug Resistant Epilepsy; Encephalitis; Epileptic Syndro | 2018 |